| Title |
Methylphenidate produces selective enhancement of declarative memory consolidation in healthy volunteers
|
|---|---|
| Published in |
Psychopharmacology, December 2011
|
| DOI | 10.1007/s00213-011-2605-9 |
| Pubmed ID | |
| Authors |
A. M. W. Linssen, E. F. P. M. Vuurman, A. Sambeth, W. J. Riedel |
| Abstract |
Methylphenidate inhibits the reuptake of dopamine and noradrenaline and is used to treat children with attention deficit hyperactivity disorder (ADHD). Besides reducing behavioral symptoms, it improves their cognitive function. There are also observations of methylphenidate-induced cognition enhancement in healthy adults, although studies in this area are relatively sparse. We assessed the possible memory-enhancing properties of methylphenidate. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 179 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Switzerland | 1 | <1% |
| Netherlands | 1 | <1% |
| France | 1 | <1% |
| Australia | 1 | <1% |
| Brazil | 1 | <1% |
| Israel | 1 | <1% |
| United Kingdom | 1 | <1% |
| Spain | 1 | <1% |
| United States | 1 | <1% |
| Other | 0 | 0% |
| Unknown | 170 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 38 | 21% |
| Student > Master | 27 | 15% |
| Student > Ph. D. Student | 22 | 12% |
| Researcher | 18 | 10% |
| Student > Doctoral Student | 10 | 6% |
| Other | 22 | 12% |
| Unknown | 42 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Psychology | 42 | 23% |
| Medicine and Dentistry | 24 | 13% |
| Agricultural and Biological Sciences | 20 | 11% |
| Neuroscience | 16 | 9% |
| Social Sciences | 5 | 3% |
| Other | 17 | 9% |
| Unknown | 55 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 July 2022.
All research outputs
#4,469,436
of 25,809,907 outputs
Outputs from Psychopharmacology
#1,096
of 5,363 outputs
Outputs of similar age
#34,276
of 251,114 outputs
Outputs of similar age from Psychopharmacology
#8
of 38 outputs
Altmetric has tracked 25,809,907 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,363 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.1. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 251,114 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.